Crystal Research Associates recent interviews
Interview with
Jeffrey Kraws, CEO
Crystal Research
(5/8/07)
Interview with
Jeffrey Kraws, CEO
Crystal Research
(3/27/07)
Interview with
Jeffrey Kraws, CEO
Crystal Research
(12/26/06)
Interview with
Jeffrey Kraws, CEO
Crystal Research
(06/23/06)

We welcome you to explore our current universe of EIO's (and quarterly updates), and invite you to be notified of future EIO's, quarterly updates, and other postings we may issue.

» View our privacy policy

DOR BioPharma, Inc. (DORB.OB - OTC.BB)

Crystal Research Associates provides independent equity research coverage of DOR BioPharma, Inc. (DORB.OB - OTC.BB), including a company snapshot, executive informational overview (EIO), and quarterly updates.

DOR BioPharma, headquartered in Miami, Florida, develops oral therapeutic products under the BioTherapeutics and BioDefense segments.

Please visit the Research Coverage link below for greater details on DOR BioPharma, including the base reports and quarterly updates.

DOR BioPharma, Inc. (DORB.OB - OTC.BB)

Research Coverage

© 2008 Crystal Research Associates. All Rights Reserved. Disclaimer | Site Map